Ma and Tyner Receive Award from AAAS

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

LI MA and JEFFREY TYNER were named the recipients of the American Association for the Advancement of Science’s Martin and Rose Wachtel Cancer Research Award.

The award honors investigators who have performed outstanding work in the field of cancer research, and have received their Ph.D. or M.D. within the last 10 years.

Tyner and Ma’s award entry essays were published in the July 2 edition of Science Translational Medicine. Both will deliver public lectures on their research July 7 at an event co-hosted by the NCI Center for Cancer Research at the NIH Lipsett Amphitheater in Bethesda, Md. They will split the award of $25,000.

Ma is an assistant professor of experimental radiation oncology at MD Anderson Cancer Center. Tyner is an assistant professor of cell, developmental and cancer biology at the Oregon Health and Science University.

Ma’s research focuses on regulating breast cancer metastasis, breast tumor radioresistance, and key breast cancer proteins and pathways. Tyner helped develop a research program that more rapidly identifies the mutations driving a patient’s cancer and accelerates development of precision treatments.

YOU MAY BE INTERESTED IN

Secretary of the U.S. Department of Health and Human Services Robert F. Kennedy Jr. appeared before the House Energy and Commerce Subcommittee on Health to defend the HHS fiscal year 2026 budget proposal, and faced criticism from several Democratic lawmakers on what they described as a lack of transparency and scientific rigor in the agency’s recent decisions.

The full-scale Russian invasion of Ukraine has devastated the Ukrainian healthcare infrastructure, disrupting cancer care, halting clinical trials, and compounding long-standing systemic challenges.  Even before the war, Ukraine’s oncology system faced major constraints: Limited access to radiotherapy equipment, outdated chemotherapy supply chains, and workforce shortages. The invasion intensified these issues—cancer hospitals were damaged, warehouses destroyed,...

Patients affected by cancer are increasingly turning to artificial intelligence-powered chatbots, such as ChatGPT and Gemini, for answers to pressing health questions. These tools, available around the clock and free from geographic or scheduling constraints, are appealing when access to medical professionals is limited by financial, language, logistical, or emotional barriers. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login